Abstract:A microfluidic chip featuring parallel gradient-generating networks etched on glass plate was designed and fabricated. The dam and weir structures were fabricated to facilitate cell positioning and seeding, respectively. The microchip contains five gradient generators and 30 cell chambers where the resulted concentration gradients of drugs are delivered to stimulate the on-chip cultured cells. This microfluidics exploits the advantage of lab-on-a-chip technology by integrating the generation of drug concentration gradients and a series of cell operations including seeding, culture, stimulation and staining into a chip. Steady parallel concentration gradients were generated by flowing two fluids in each network. The microchip described above was applied in studying the role of reduced glutathione (GSH) in MCF-7 cells’ chemotherapy sensitivity. The parental breast cancer cell line, MCF-7 and the derived adriamycin resistant cell line MCF-7adm were treated with concentration gradients of arsenic trioxide (ATO) and N-acetyl cysteine (NAC) for GSH modulation, followed by exposure to adriamycin. The intracellular GSH level and cell viability were assessed by fluorescence image analysis. GSH levels of both cell lines were down-regulated upon ATO treatment and up-regulated upon NAC treatment. For both cell lines, suppression of intracellular GSH by treatment with ATO has been shown to increase chemotherapy sensitivity; conversely, elevation of intracellular GSH by treatment with NAC leads to increased drug resistance. The results indicated that high intracellular GSH level has negative effect on chemotherapy sensitivity, while depletion of cellular GSH may serve as an effective way to improve chemotherapy sensitivity. The integrated microfluidic chip is able to perform multiparametric pharmacological profiling with easy operation, thus, holds great potential for extrapolation to the high-content drug screening.

On-chip investigation of cell-drug interactions.

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Research of Integrated Cellular Chip Based on Microfabrication

Microfluidic Cell Culture Systems for Drug Research

Recent Advances in the Determination of Intracellular Contents in Individual Cells Using Microfluidic Devices

Recent Progress in Lab-on-a-chip for Pharmaceutical Analysis and Pharmacological/toxicological Test

Advances in research of cell-based drug screening by microfluidic chip

Drug effects analysis on cells using a high throughput microfluidic chip

From Chips-in-Lab to Point-of-Care Live Cell Device: Development of a Microfluidic Device for On-Site Cell Culture and High-Throughput Drug Screening

[Research progress of integrating electrical impedance sensors with microfluidic chips in cell detection]

Application of microfluidic chips in anticancer drug screening

Cell docking and on-chip monitoring of cellular reactions with a controlled concentration gradient on a microfluidic device.

Parallel Microfluidic Networks for Studying Cellular Response to Chemical Modulation

Integrated Microfluidic Devices for Combinatorial Cell-Based Assays

Exploring the Mechanism of Contact-Dependent Cell-Cell Communication on Chemosensitivity Based on Single-Cell High-Throughput Drug Screening Platform

Dose-Dependent Cell-Based Assays in V-Shaped Microfluidic Channels

Recent Development in Microfluidic Chips for in Vitro Cell-based Research

Engineering Organoids-on-chips for Drug Testing and Evaluation

Recent progress of microfluidic technology for pharmaceutical analysis

On-Chip Cell-Cell Interaction Monitoring at Single-Cell Level by Efficient Immobilization of Multiple Cells in Adjustable Quantities

Recent Developments in Microfluidic Chip for in vitro Cell-based Research